
Meet the influencers calling drinking bleach ‘health revolution'
'I gargled three drops with a very sore throat and it was gone the next day,' Dominguez said. 'My friend said it cured her Covid. I am new to it and don't know much, but I'm a believer.'
Ignoring health authority warnings around the ingesting of chlorine dioxide, alternative health influencers are recommending people drink it with water, spray it on skin and even use it in enemas as a 'cure' for everything from measles to cancer, HIV and autism.
First touted as a 'miracle cure' in the United States in the mid-1990s, the German biophysical researcher Andreas Kalcker is one of the earliest and most prominent proponents, describing chlorine dioxide as 'possibly the greatest medical discovery of the last hundred years'.
But the so-called bleacher movement received relatively little attention until President Trump, at the height of the Covid-19 outbreak in 2020, suggested coronavirus sufferers 'inject' disinfectant. He later claimed he was being sarcastic.
Yet adherents kept pushing the theory, largely on the fringes until they were embraced by Trump's second-term health secretary, the vaccine sceptic Robert F Kennedy Jr.
Kennedy, who has built a huge following promoting anti-vaccine conspiracy theories, has not explicitly promoted chlorine dioxide as a treatment. But during his Senate confirmation hearing in January, he referred to the chemical substance and praised Trump for 'looking at all of the different remedies' for Covid, 'including even chlorine dioxide'.
• 'RFK Jr is a disaster': staff describe chaos in 'anti-science' regime
In recent months, interest has exploded among social media groups such as those called 'Chlorine Dioxide' and 'Secret Mineral', some of which have added thousands of new followers on Facebook from the US, UK and across the world.
In the groups, users discuss their growing mistrust of science and the medical community, particularly in the wake of the pandemic.
In May, the movement was given its first mainstream boost when Kalcker was invited to a 'Truth Seekers' conference at the Trump National Doral hotel in Miami, a two-day event featuring anti-vaxxers and conspiracy theorists.
Though the conference was a closed event, The Times found video and photographs posted on the social media accounts of attendees. A number of products appeared to be on sale to ticket-holders, including chlorine dioxide-based nasal sprays sold by Michelle Herman.
Kalcker, who claims to be the inventor of the most commonly used chlorine dioxide solution, marketed as Miracle Mineral Solution (MMS), talked up the health benefits to the thousand-strong audience, some of whom paid $2,000 to attend.
'It's very easy, you drink it all the day,' he told attendees in a speech that was recorded on video. 'The important thing is not to drink a lot in the morning. More is not better, more often is better. It works on cancer … it helps necrotic fingers grow back. It's simply amazing.'
Influencers and peddlers of chlorine dioxide make money by selling self-published books about the supposed treatment, by marketing MMS and by posting how-to videos on their online platforms.
Half a dozen members of the most popular chlorine dioxide Facebook group, which has 30,000 members, told The Times they used the solution for minor ailments such as a sore throat or psoriatic skin. However, some said they were using it as the sole treatment for diseases as serious as cancer and neurodevelopmental disorders such as autism — against all medical advice.
Dominguez, a 31-year-old mother of two, said she kept her use of chlorine dioxide on the 'down low' because 'if you look at regular search engines like Google they make it seem like something bad, so that no one uses it. Think of how big pharma would lose money when this is used for so many different things.'
In 2019, the Food and Drug Administration (FDA) warned that 'ingesting these products is the same as drinking bleach', listing possible side-effects including abdominal pain, nausea, vomiting, diarrhoea and acute liver failure.
The American Association of Poison Control Centers recorded more than 16,000 cases of chlorine dioxide poisoning, including 2,500 cases of children under 12, in 2020, the last year it published figures on the trend. Many of those individuals suffered serious side-effects, the group noted, including a six-year-old autistic girl who required hospital treatment for liver failure.
'The problem with chlorine dioxide is that these benefits people are claiming are really not proven,' said Dr Josh King, medical director at the Maryland Poison Center and an associate professor at the University of Maryland School of Medicine.
Fiona O'Leary, an anti-chlorine dioxide campaigner, said she told managers of Trump National Doral of her concerns about the Truth Seekers event in a failed bid to get it cancelled. Speaking to The Times, she said of the bleacher movement: 'It's always been crazy, but this is totally different to what we've seen before.'
Several of the listed speakers and special guests at the Truth Seekers conference have previously faced legal action or been investigated by the authorities. In 2021, Kalcker was charged in Argentina with falsely promoting a type of toxic bleach as a medical cure after the death of a five-year-old boy whose parents gave him Kalcker's chlorine dioxide solution in the belief it would ward off Covid-19.
In a response to The Times, Kalcker wrote: 'As a biophysics researcher focused on electromolecular medicine, I believe it's crucial that any discussion about chlorine dioxide solution is grounded in scientific understanding.'
Mark Grenon, who attended the event as a special guest, was the main distributor of MMS in the US before he was sentenced in 2023 to five years in federal prison for selling an 'unapproved and misbranded drug'. Grenon, the self-styled archbishop of the Genesis II Church of Health and Healing in Florida, was released this year on probation.
Also at the conference was Kerri Rivera, a former Chicago real estate agent turned pseudo medical expert who has more than 17,000 followers on Instagram. She encourages parents to give their autistic children doses of chlorine dioxide as part of a 'protocol' that rids the body of parasites she claims causes autism. Experts say autism is a neurological condition that is not caused by viruses, vaccines or parasites and for which there is no known cure.
The authorities in Germany, where Rivera was believed to be living at some point, investigated accusations that she had caused bodily harm to a child, though no charges were filed. Rivera, speaking in both Spanish and English, describes herself on Instagram as 'a woman whose life changed' when her son was diagnosed with autism and claims that for the past 19 years she has 'helped many children lose their autism diagnosis'. On Instagram and in private online support groups she recommends parents giving drops to children orally, through enemas, and in baths.
'Almost all of the people with autism have high levels of pathogens; virus, bacteria, parasites and heavy metals,' Rivera wrote in her book Healing the Symptoms Known as Autism, which was removed by Amazon in 2019. 'Chlorine dioxide kills pathogens and helps the body to detoxify itself,' she added.
When reached by The Times, Rivera declined to address the allegations, but has previously defended chlorine dioxide and her credentials, saying: 'This is a medical issue. I have a degree in homeopathy and work with MDs and PhD scientists.'
In April, a report by the Centers for Disease Control and Prevention (CDC) found that autism diagnoses are increasing but attributed the rise to better early detection and evaluation services. Immediately after, Kennedy contradicted the CDC, repeating the claim that 'environmental toxins' and the prevalence of food additives were behind the spike.
Emma Dalmayne, an autism campaigner who has several autistic children and was diagnosed herself, said giving any legitimacy to bleach cures was dangerous. 'It's one thing if a consenting adult decides to take this, but we are seeing children held down and given enemas,' she told The Times. 'Sometimes drops are put into their babies' bottles.'
Dalmayne said her advocacy has attracted hate mail, threats and even bullets through the post, believed to be sent by members of the bleacher community trying to 'silence' her.
She called the chlorine dioxide proponents 'very clever, preying on fears and insecurities', adding: 'Parents are jumping on these 'cures' because they don't want to face the fact that they gave birth to an autistic child. And the kids can't advocate for themselves. It's heartbreaking, actually.'
Dalmayne, a 49-year-old mother of five, joined one of Rivera's support groups and shared screenshots with The Times of messages that appeared to show parents reporting vomiting, rashes, seizures and chemical-smelling urine in their severely autistic children after administering chlorine dioxide.
One mother called 'Katrina' asked Rivera: 'Hello Kerri, when a child has pain during detox but can't tell me because they can't talk or can't understand, and are crying out what (sic) you recommend, what I might give for pain or calm?' They did not receive a response that could be seen on the site.
But in reply to another message of concern about the enema protocol, an administrator for Rivera's group wrote: 'If you move slowly and respect the child's tolerance, there is nothing to fear.'
Dalmayne considered it child abuse and has lodged a petition on change.org to have Instagram remove Rivera's account, which has attracted more than 35,000 signatories. Dalmayne said she was waiting for a response from Instagram.
Most of the campaigning against chlorine dioxide therapies has come from outside the US. Dalmayne is based in London and O'Leary in Ireland. O'Leary speculates it may be because non-conventional therapies are much more widely accepted in America, where the market is less tightly regulated.
'The problem is there isn't the legislation,' said O'Leary, who describes four of her five children as being on the autistic 'spectrum'. 'Years have gone by where we've been protesting and raising awareness and all of these things.'
Meanwhile, several Truth Seekers speakers and guests have praised Kennedy on their social media accounts. Others have posted pictures taken with him before he took up the role. Herman said she met Kennedy in 2023, when she spoke to him 'for 30 minutes' about chlorine dioxide. 'He listened intently, indicated he was not familiar with it but was nonetheless very intrigued and asked for more information,' she said. 'I've been connecting with many of the high-profile medical freedom players to educate them on the benefits of chlorine dioxide and to counteract the misinformation.'
After several chlorine dioxide proponents, including Herman, called on Kennedy to remove federal warnings about the use of chlorine dioxide, an FDA web page featuring a warning about chlorine dioxide's life-threatening effects was taken down in April and replaced with a 'page not found' notice. The page is still not functioning.
An FDA spokesman told The Times: 'There is not any new FDA action and the general public health position on [chlorine dioxide] being dangerous has not changed.'
At the same time, alternative health proponents like Herman are cheering on what they call a 'health revolution'. 'The wholesale reform of these agencies is long overdue and we are thrilled that RFK Jr is in charge,' Herman said. 'A real healthcare can finally ensue. We are excited to have played a part in this revolution.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
27 minutes ago
- Daily Mail
Boston boy, 4, suffers terrifying HIV scare moments after mistaking city's drug addicts for ZOMBIES
A four-year-old boy suffered a terrifying HIV scare after he was pricked in the foot by a dirty hypodermic needle that had been discarded by the 'zombie' drug addicts who have taken over the streets of Boston. The youngster was jabbed by the needle while attending a birthday party in a South Boston park near his family home on July 11. He ran out of the play area without any shoes on and screamed as a needle stuck out of the big toe on his left foot, his mother Caroline Flynn recalled. 'I was freaking out. I was scared,' Flynn told The Boston Herald, noting how 'there was leftover blood in that needle'. He was rushed to the emergency room at nearby Boston Medical Center where he underwent extensive blood testing, got an x-ray, and was prescribed multiple anti-HIV preventative medicines, which he reportedly 'wasn't able to tolerate'. After a month of panic, Flynn finally got some 'relief' on Wednesday when doctors informed her that her son's 'blood tests came back negative' for HIV and hepatitis. Flynn, who is urging Massachusetts lawmakers to address the crippling opioid crisis, has now heartbreakingly shared how her son mistook the drug addicts that stagger through Boston as 'zombies'. 'We were sitting down at McDonald's and he looked out the window and said, "Look Mom, zombies!",' Flynn told the newspaper. Drug addicts stumble through Boston's city parks and streets, and are known to openly shoot up in public. Drug users are pictured smoking and shooting up at the intersection of Atkinson and Southampton Street in the South Boston neighborhood She says her son watched as addicts stumbled around public streets, claiming that some were even openly shooting up. He witnessed visibly intoxicated people pushing rusty wheelchairs and old shopping carts around. Others rode around on city-operated rental bicycles, she claimed. Flynn has called on legislators to urgently take action, telling the newspaper how 'something needs to be done' to combat the drugs epidemic. The mother even suggested that anyone caught shooting up in public be arrested and forced to undergo addiction treatment. Boston's raging drug problem has been in the spotlight after residents lashed out at Democrat Mayor Michelle Wu, blaming her policies that allegedly enable drug use. Locals claim Wu's controversial decision to hand out free crack pipe syringes and other paraphernalia to addicts in 2022 has helped fuel the problems. While her administration pitched the move as 'harm reduction,' critics have countered that all she's done is increase the permissiveness of public drug use in Boston. Massachusetts state Sen. Nick Collins is among those pushing for a crackdown on the city's open-air drug markets and has branded the Flynn family's case as 'collateral damage caused by the ongoing crisis at Mass and Cass'. The intersection of Massachusetts Avenue and Melnea Cass Boulevard, known as 'Mass and Cass,' is notorious for open-air drug usage. Wu has tried to clear out the crime-ridden area, dubbed 'Methadone Mile', by trying to take down tent encampments. But instead of isolating the drug crisis, it has amplified and spread - further plaguing the historic city. Flynn's son stepped on a needle in park near the corner of Columbia Road and Mercer Street, less than two miles away from the so-called Methadone Mile. 'Nobody should have to worry about stepping on a needle in a public park,' Collins told the Herald, adding that we 'owe it to the boy' to intervene. The senator called for a reform of the city's public health policies, as well as protocols on civil interventions and discharge policies. Residents from across Boston have complained that the Mass and Cass crackdown has led to 'out of control' spillover into their neighborhoods. The streets of once-pristine communities, including ritzy Beacon Hill where the median housing price is $2.8million, have been left littered with dangerous needles. A clean-up crew supported by the Newmarket Business Improvement District has estimated they pick up about 1,000 needles a day across Boston. Wu's office, in a statement issued to the newspaper Thursday morning, reiterated that outdoor drug use is 'illegal and unacceptable'. The mayor's office said they are using 'active and continuous police enforcement' in drug-stricken areas and working to 'transition individuals into recovery programs'. The city is said to be focused on needle pickup and has expanded working hours for its needle collection teams. Boston has also ended its outdoor and weekend syringe exchange. 'No family should have to worry about their children's safety playing outside,' the statement added.


The Guardian
27 minutes ago
- The Guardian
Ozempic didn't work for me. I was furious
I'm 46 years old and I have been on a diet since I was 11. For as long as I can remember, eating has given me comfort. As a kid, I lied to my friends' parents so I could eat a second dinner at their house. I've never wanted just one cookie – I'd eat 12 and only stop when I felt physically ill, and sometimes not even then. In nearly every photo of me as a teenager I'm wincing, sucking in my stomach, trying to pose. I never really enjoyed the taste of these foods, nor was I happy with myself after eating them. They came with a side of guilt: you don't deserve this. This relentless food noise trapped me in a cycle of wanting to eat, then shaming myself for doing it. I spent inordinate energy hating my too tall, too big body. I always felt simultaneously like not enough and too much. Now, GLP-1 drugs like Ozempic, Wegovy and Mounjaro are being hyped as an easy fix to obesity. Their manufacturers have experienced significant revenue growth credited to the drugs' popularity; for instance, Eli Lilly recently announced 38% yearly growth, credited in part to sales of Zepbound and Mounjaro. Media headlines tout the changes in weight and appetite for those who take them. But what if the 'miracle' doesn't work for you? Being diagnosed with diabetes at age 27 threw me deeper into a shame spiral. At the time, my doctor clinically defined me as obese. That, along with the prognosis of a deficient pancreas, felt like punishment for decades of failing to control my overeating. Given my family history of diabetes – my grandpa had it – the doctor diagnosed me as type 2 and recommended dramatic lifestyle adjustments, including carb counting and daily exercise. She also did an A1C test, which measures average blood sugar levels for three months. A non-diabetic's result would be under 5.7%. Mine was 7.7%. This diagnosis felt like being sentenced to lifelong obsession. Food already controlled me, and now it had even more power. Over the next five years, I worked with a nutritionist and psychotherapist. I trained for a 200-mile relay race with friends. I did Weight Watchers, went to Overeaters Anonymous, worked the 12-step program, and used apps like Noom and My Fitness Pal. I lost 50lb. Still, I remained overweight according to the BMI chart, and my A1C didn't budge, which confounded my primary care doctor. She referred me to an endocrinologist who specialized in metabolic health. Six months later, when my appointment finally arrived, my A1C had shot up to 9.1%. That should not have happened while I shed pounds. She declared I was misdiagnosed: type 2 diabetics' bodies make insulin, which helps regulate blood sugar, but don't use it effectively. But I was actually type 1, an autoimmune condition where the body stops producing insulin. I would be dependent on insulin injections from that point forward. Living with diabetes was taxing. I had to order a continuous glucose monitor (CGM), pen needles, insulin vials and other items – but via a specialty supplier rather than a standard pharmacy, for insurance purposes. I had to procure pre-authorization forms for medication and attend required half-day training sessions every time I wanted to try a different insulin pump or when my insurance changed. But in 2018, after five years of effort, my A1C settled in at 5.9% – a happy result for me and my doctor. But to get to a weight my doctor would approve, I still had to lose 30lb. She started me on a new drug called Ozempic. Like most people at that point, I'd never heard of it. She said it was only technically approved for type 2 patients – but some who were overweight with type 1, like me, were taking it to help with weight loss. Over the next four years, my doctor and I gradually increased my Ozempic dosage and eventually were pleased with the results: when I woke in the morning my fasting blood sugar reading was finally within the recommended range of 80-120 on my CGM. I was able to reduce my regular insulin usage. But my weight didn't change. I continued my healthier eating habits and exercised regularly with cycling, yoga and running. Still, the scale didn't move. In 2022, when Ozempic was becoming a household name, I suddenly had two problems. First, my doctor confirmed I was already on the highest available dose, so taking more wouldn't help me lose weight. Second, because the drugs were now approved for general weight loss, I might have trouble filling my prescription. A global shortage followed, and I went four months without, eventually switching to Mounjaro because it was available. My already-thin friends started taking GLP-1s, and I couldn't avoid chatter about the 'skinny shot'. 'I'm not even hungry! I don't even think about food!' they'd say. But I didn't experience this quieting of the voices in my head telling me I was hungry all the time, and I wondered why. I was furious. As my friends celebrated their new bodies, I wondered, again, what was wrong with mine. My diabetes was under control, but I was also existing at the margins of a miracle. An estimated 15% of all GLP-1 users are so-called 'non-responders' to the weight loss effect, according to Atlanta-based physician Dr Cristina Del Toro Badessa. Lucas Veritas, a GLP-1 user from Montreal and author of The GLP-1 Effect newsletter, highlighted clinical trials showing that approximately 13% of people taking semaglutide (the active ingredient in Ozempic and Wegovy) and about 9% of those taking tirzepatide (found in Mounjaro and Zepbound) did not lose more than 5% of their body weight. 'The meds are highly effective for a majority of patients but there is still a percentage who don't lose a clinically significant percentage of body weight. Everyone's physiology is a little different,' said Veronica Johnson MD, an obesity medicine specialist in Chicago. Recent research has identified a gene that may help predict who will successfully lose weight with GLP-1 medications. Sign up to Well Actually Practical advice, expert insights and answers to your questions about how to live a good life after newsletter promotion Additionally, according to a recent study comparing GLP-1 medications to bariatric surgery, 'real world' cohorts lost less weight than what drug companies reported in their trials: about 5% of their body weight, compared with the 15% reported for semaglutide and the 20–25% for tirzepatide in pharma-funded studies. Nicoletta LaMarca-Sacco, 56, a former Ozempic user in New York, also didn't lose weight after a year of use. 'I've always been a squishy mom and will continue to be,' she said. 'It just didn't work for me.' She expected the drug would quiet more of the internal chatter telling her she needed to snack. 'It did help, but only to a small degree,' she said. 'When we consider these drugs, they need to be combined with other markers of good health like diet, exercise, even stress management,' said Dr Raj Dasgupta, an ABIM Quadruple board-certified physician in Los Angeles. He said his patients sometimes had unrealistic expectations about how quickly and dramatically they will drop extra pounds. He explained that for someone who is overweight, shedding even a small amount of weight can improve heart and kidney function, adding: 'The bar has been set too high for weight loss.' 'What's dangerous,' Badessa said, 'is the dominant societal narrative that these are 'magic shots' for weight loss.' Veritas agreed: 'Expectations are sky-high. People see all the before/after photos and expect an easy ride.' 'It feels similar to any other time the diet industry has thrown marketing momentum behind one particular 'fix',' Virginia Sole-Smith, author of Fat Talk, told me about the current hype. 'There's excitement that we've found a 'silver bullet', then it silences any other narratives and experiences about it.' I had definitely been looking for an elixir to rid me of body mass. Then I discovered that diabetes itself might be the reason I wasn't losing weight. Andrew Koutnik, a metabolic research scientist, said that GLP-1s typically lead to significant weight loss for people with obesity (15-25% of their body weight). However, people with diabetes generally lost less weight, proportionally: for type 2, an average of 8-11%; for type 1, about 8-12%. 'While we don't know why this is occurring, prior data suggests the drug's metabolic effects may be tied to how well the body manages glucose,' Koutnik said. GLP-1s are designed to coax the body into making and using insulin more efficiently, he explained. But for someone with type 1 diabetes, meaning their pancreas cannot make insulin, that's like installing a turbocharger on a car with no engine – there's nothing to boost. That said, he clarified, these drugs aren't entirely useless for people with type 1. GLP-1s slow digestion and suppress appetite, which can lead to fewer snacks and less carb-heavy meals. That might nudge blood sugar in the right direction, but it's more of a side-effect. 'The actual impact on blood sugar control is minimal: less than a 1% drop in A1C,' Koutnik explained. The psychological fallout of being a non-responder can be devastating. It was more fodder for my destructive inner dialogue: Why won't my body just comply? Alyson Curtis, a therapist based in New York, works with patients who feel isolated as they see others losing weight and don't have the same result. I told her how unfair it felt and she agreed the loss of agency can be a lot to process. 'I hear the 'thin fantasy' constantly from patients – it's a dream to fit into societal norms,' Curtis added, 'but what they're really saying is they want to be accepted, cherished, adored.' She helps patients reframe success to focus on healthy outcomes beyond weight loss – like how the Health at Every Size (HAES) movement centers on overall wellbeing. Still, these drugs are here to stay. Johnson pointed to recent innovations like CagriSema, a compound drug bringing together an amylin agonist and a GLP-1. In trials, CagriSema helped reduce blood sugar spikes after meals and can also contribute to weight loss. 'The hormone called amylin is normally released by the same cells that make insulin – which type 1 diabetics lack,' Koutnik said. He added that amylin helps slow digestion and also lowers levels of glucagon, which could help better manage blood sugar. Society seems to have rewritten ideas about health, worth and willpower through the lens of these astonishing drugs. I figured I could, too. I've tried to quiet the inner voice that's shaming me into thinking I'm a failure for not losing more weight. Forging self-acceptance from deep frustration, I am realizing there is nothing inherently 'wrong' with my body – I am simply among those for whom the current medications produce a partial benefit. Learning that I'm not alone has helped curb my body shame. I am grateful that GLP-1s have helped me with blood sugar control, minimizing my risk of complications from diabetes. 'When we focus on the miracle weight loss narrative, we ignore their real value in helping people with diabetes, adding to the discourse of body shaming, which is never health-promoting,' said Sole-Smith. I've been trying to shift my focus from weight loss to improving my relationship with food. For me, that's learning to eat with more intention and maybe even a little joy. Hopefully, I can come to appreciate my right to the occasional indulgence without self-recrimination. And on my next birthday, I want to celebrate with the most delicious symbol of self-acceptance: a guilt-free piece of cake.


Metro
an hour ago
- Metro
Cost of Mounjaro weight-loss drug to go up by 170% in the UK within weeks
The manufacturers of a new weight-loss drug recently rolled out by the NHS are upping their prices by 170%. Eli Lilly is increasing the price of Mounjaro, which is also used to treat type 2 diabetes, in the UK from September. It comes amid a White House push to get drug makers to raise their prices overseas in order to cut prices in the US. The price for a month's supply of the highest dose of Mounjaro, a 15mg KwikPen, will increase from £122 to £330. The cost of a 2.5mg pen, the lowest dose available, will rise from £92 to £133 from September 1. This means the annual cost of the 15mg dose will increase from £1,586 a year to £4,290. This higher price will affect anyone in the UK who pays for the medicine privately. However, it doesn't impact those who are prescribed the medicine through the NHS, as these prices were set with a separate deal, a Lilly spokesperson said. The manufacturer said it agreed to a list price 'significantly below' others in Europe to prevent delaying Mounjaro's availability on the NHS. 'We are now aligning the list price more consistently,' Lilly said. Dr Leyla Hannbeck, chief executive of the Independent Pharmacies Association, told the Daily Mail: 'We are shocked and very disappointed by this huge more than doubling of the wholesale cost of Mounjaro by the manufacturer Eli Lilly. 'British patients must not become pawns in a wider dispute about the costs of medicines arising from President Trump's recent letter to the US drug manufacturers.' Mounjaro was launched in the UK in February 2024, compared to rival Novo Nordisk's Wegovy treatment which has been available since September 2023. Lilly said it was working with private UK healthcare providers to ensure patients can keep accessing the medicine and potentially negotiate discounts which could be passed on to customers. The manufacturer also said clinical research had proved the effectiveness of the Mounjaro injections, saying the drug had demonstrated its 'value'. Known as tirzepatide and marketed under the brand name Mounjaro, the drug injection helps people to manage blood sugar. It works in a similar way to semaglutide – sold as Ozempic, Wegovy and Rybelsus – which are in the same family of glucagon-like peptide-1 (GLP-1) agonist medications. Administered by weekly injections, tirzepatide changes hormone levels in the body to slow down how fast food is digested. This make you feel more full, for longer, on less food. Alongside healthy eating and exercise, this can help people lose weight. But there are pros and cons to taking the weight-loss drug, including some side effects. Short-term: Sickness and nausea Indigestion & heartburn Constipation Diarrhoea Headaches Injection site reactions (redness, bruising, tenderness, swelling) Gallstones and pancreatitis (in rare instances) Positive impacts on heart health (in some instances) Long-term: Weight loss Muscle mass reduction Slower metabolism Insulin resistance A spokesperson for Lilly said: 'Following a review, Lilly will increase the UK list price for Mounjaro (tirzepatide) from September 1 to address pricing inconsistencies compared to other developed countries, including in Europe. 'In parallel, we have reached an agreement with the NHS to ensure continued supply and patient access. 'While Lilly does not determine the prices that private healthcare providers set, we are working with them to maintain patient access. 'The UK was one of the first countries where Lilly launched Mounjaro, and our priority was to bring it to patients as quickly as possible during a time of limited supply of GLP-1 RA treatments for type 2 diabetes. 'At launch, Lilly agreed to a UK list price that is significantly below the European average to prevent delays in NHS availability. 'With changes in the environment and new clinical evidence supporting the value of Mounjaro, we are now aligning the list price more consistently to ensure fair global contributions to the cost of innovation.' The US pays more for prescription drugs than any other country, often nearly three times as much as other developed nations. More Trending President Donald Trump says he wants to narrow this gap to stop Americans from being 'ripped off'. An NHS England spokesperson said: 'Licensed, cost-effective weight loss medication, such as tirzepatide (Mounjaro) provides a valuable tool to support people to reach a healthier weight and the wider health and lifestyle benefits that offers. 'The approved list price increase will not affect NHS commissioning of tirzepatide in England for eligible people living with obesity, based on clinical priority, or as a treatment for type 2 diabetes. 'Anyone with questions about their private tirzepatide prescription should contact their private provider.' Get in touch with our news team by emailing us at webnews@ For more stories like this, check our news page. MORE: Chikungunya cases double in UK as expert warns 'all it takes is one mosquito bite' MORE: What is AI psychosis? The rise in people thinking chatbots are real or godlike MORE: Man, 60, gave himself rare condition after going to ChatGPT for diet advice